CCL2 and type 2 diabetes mellitus: Interestingly, however, previous findings have indicated the potential role of AT2R in mediating the release of MCP-1 (63), which may explain the sustained elevation of this biomarker in the T2DM-HT group, given that a large proportion of patients were on ARBs.